• About CLS
  • IR
  • News & Media
  • Log in
  • USA
Clinical Laser
  • Focal Therapy
    • Procedure
    • Principles
  • TRANBERG®
    • Thermal Therapy System
    • Thermoguide softwareConcept of Thermoguide, soon to come
    • Applicators & Accessories
    • Certificates
  • Publications
    • Posters
  • Contact
    • Contact
    • Support
Welcome to Clinical Laserthermia Systems.
Please choose a country or region.

Subscribe to our mailing list





CLS Innovation for Laser Ablation procedures

Laser applicators and accessories


TRANBERG®

TRANBERG® |Thermal Therapy System
– High precision through superior thermal control

MRI-guided laser ablation

Superior tumor detection and ablation confirmation

Home / mikael

The TRANBERG®|Thermal Therapy System has not yet a market clearance for Immune stimulating interstitial laser thermotherapy (imILT®) by the Food and Drug Administration (FDA) in the United States of America (USA)

WHERE TO FIND US

Clinical Laserthermia Systems
Americas Inc.

5 Musick, Irvine
CA 92618, USA

Phone
Office: (949) 900 – 6833 ext. 112
Cell: (650) 219-4111
E-mail: contact@clinicallaser.com

 

tuv-ce-mark-q_en_iso135

Subscribe to our news!

Visit us on LinkedIn.

DISTRIBUTORS

MRI Interventions

5 Musick, Irvine
CA 92618, USA

Phone
Phone: (949) 900 6833
Fax: (949)900 6834
E-mail: info@mriinterventions.com

  • About CLS
    • Strategy
    • Market
    • Career
    • History
  • IR
    • Rapporter
    • Aktieinformation
    • Aktiekapital
    • Bolagsordning
    • Emissionsdokument
    • Finansiell kalender
    • Informationspolicy
    • Prenumeration
  • News & Media
    • Press releases
    • Newsletter
    • Events
    • Video
  • Log in
  • USA
    • USA USA
  • Focal Therapy
    • Procedure
    • Principles
  • TRANBERG®
    • Thermal Therapy System
    • Thermoguide software
    • Applicators & Accessories
    • Certificates
  • Publications
    • Posters
  • Contact
    • Contact
    • Support
The TRANBERG®|Thermal Therapy System has not yet a market clearance for Immune stimulating interstitial laser thermotherapy (imILT®)
by the Food and Drug Administration (FDA) in the United States of America (USA)